Meizhong Jiahe [02453] is currently reported at 8.14 Hong Kong dollars, with an increase of 10.30%.
As of 10:38, Meizhong Jiahe [02453] reported 8.14 Hong Kong dollars, up 0.76 Hong Kong dollars or 10.30% from yesterday's closing price of 7.38 Hong Kong dollars, with a transaction volume of 3.4884 million Hong Kong dollars. Today's highest price is 8.14 Hong Kong dollars, the lowest price is 7.16 Hong Kong dollars. Based on yesterday's closing price, the 10-day average price is 7.94 Hong Kong dollars, the 50-day average price is 12.78 Hong Kong dollars, and the current PE is -11.93 times, with a 14-day strength index of 26.37.
Meizhong Jiahhe (02453.HK) suggests adopting the Listed in Hong Kong incentive plan.
Gelonghui announced on January 3 that Meizhong Jiahe (02453.HK) has resolved on January 3, 2025, to propose the adoption of the company's incentive plan for shares Listed in Hong Kong. The incentive plan will take effect after being reviewed and approved by the company's shareholders at the upcoming extraordinary general meeting. The incentive plan aims to (i) promote the company's long-term sustainable development and achievement of performance goals; (ii) closely align the interests of the incentivized parties with those of shareholders, investors, and the company to enhance corporate cohesion and maximize corporate value; and (iii) improve the company's incentive mechanism to attract, motivate, and retain those who are continuously committed to the company.
Concord Healthcare Group to Consult With Private American Academic Medical Center for Medical, Administrative Effectiveness
Hong Kong stock movement | Meizhong Jiahe (02453) rose over 5% during trading after signing a cooperation agreement with Mayo Clinic.
Meizhong Jiahe (02453) rose more than 5% during trading. As of the time of publication, it increased by 4.44%, priced at 13.16 Hong Kong dollars, with a trading volume of 23.7271 million Hong Kong dollars.
Meizhong Jiahe (02453.HK): Mayo Clinic International plans to provide the group with advisory services regarding organizational goals and clinical practices.
Gelonghui, January 2 | Meizhong Jiahe (02453.HK) announced that recently, the company has entered into a cooperation agreement with the Mayo Foundation for Medical Education and Research. According to this agreement, Mayo Clinic International agrees to provide consultation services regarding organizational goals and clinical practices to the group. The agreement is valid for three (3) years. The Board of Directors emphasizes that the implementation of the cooperation establishes a foundation for long-term collaboration between both parties, and this cooperation must be formalized after a clear scope of work is signed.
[Hong Kong Stock Connect] Meizhong Jiahe (02453) surged nearly 30%, previously triggering the market adjustment mechanism. The company is expected to benefit from the new medical insurance policy in Guangzhou.
Jingu Financial News | Meizhong Jiahe (02453) stock price soared, triggering the market adjustment mechanism and entering a cooling-off period; as of the time of this report, it has increased by 29.45%, priced at 14.24 Hong Kong dollars, with a transaction volume of 16.861 million Hong Kong dollars. In terms of news, recently, the Guangzhou Medical Insurance Bureau and ten other departments jointly issued the "Notification on Several Measures for Building an Open Multilayer Medical Insurance System in Guangzhou" (hereinafter referred to as the "Notification"). This new policy focuses on three dimensions, with a total of seventeen measures, aimed at supporting the effective connection and supplementation of commercial health Insurance and the basic medical security system, promoting the innovative design of commercial health Insurance products, and opening up.
Express News | Concord Healthcare - Zgc Tech Leasing to Provide Finance Lease Service to Co by Sale & Leaseback of Medical Equipment for RMB200 Mln
Meizhong Jiahe (02453.HK): Proton therapy equipment medical instruments registration application has been approved.
On December 9th, Meizhong Jiahe (02453.HK) announced that Guangzhou Taihe Cancer Hospital Co., Ltd. (operated under the name of Guangzhou Taihe Cancer Hospital, in which the company owns 80% equity) has purchased a customized proton therapy equipment and started clinical trials with this equipment. The company submitted a large medical equipment configuration license application for the proton therapy equipment to the National Health Commission of China on April 29, 2024, and the application was approved by the National Health Commission on September 13, 2024.
Express News | Concord Healthcare - Approval on Application for Registration Certificate for Medical Device for Proton Therapy Equipment
Would Concord Healthcare Group (HKG:2453) Be Better Off With Less Debt?
Concord Healthcare Group Posts 6% Decline in H1 Loss
CONCORD HC GP: SUPPLEMENTAL ANNOUNCEMENT TO INTERIM RESULTSANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024AND INTERIM REPORT 2024
Meinian Health [02453] is now trading at 21.3 Hong Kong dollars, with a gain of 11.52%.
As of 09:37, Meixin Jiahe [02453] reported a price of 21.3 Hong Kong dollars, up 2.2 Hong Kong dollars or 11.52% from the previous closing price of 19.1 Hong Kong dollars. The turnover is 23.7774 million Hong Kong dollars, with today's highest price at 21.3 Hong Kong dollars and the lowest price at 18.12 Hong Kong dollars. Based on the previous day's closing price, the 10-day average price is 14.85 Hong Kong dollars, and the 50-day average price is 22.24 Hong Kong dollars. The current PE ratio is -30.88 times, and the 14-day relative strength index is 63.16.
Meidubridge (02453) pledged 64.1 million domestic shares held by the controlling shareholder shanghai Medical Star.
Meidkajiahe (02453) announced that in accordance with the agreement previously entered into between the company and Zhongcheng on July 10, 2024...
Hong Kong stock market anomaly | Some Hong Kong-listed symbols surged in the morning, shiyue daotian (09676) soared 4.8 times at one point, autos (02443) once rose more than 3 times.
Some of the Hong Kong Stock Connect symbols were sought after in the morning session, as of the time of publication, autostreets (02443) rose by 172.4%, at 13.62 Hong Kong dollars; shiyue daotian (09676) rose by 75%, at 28 Hong Kong dollars.
CONCORD HC GP: Interim Report 2024
Mei Zhong Jia He (02453.HK): Pan Li Chen appointed as Secretary of the Board of Directors.
On August 29th, Gelonghui announced that Shibo Tao has been transferred from executive director to non-executive director and resigned as secretary to the board of directors due to changes in work arrangements, effective from August 29, 2024. After Mr. Shi resigned as secretary to the board of directors, Pan Lichen will be appointed as the secretary to the board of directors.
Meichong Jiahe (02453) released its interim results, with a net loss attributable to the mother of 0.182 billion yuan, a year-on-year decrease of 6.38%.
China Meihua BioTech (02453) released its performance for the six months ending on June 30, 2024, during which the group achieved income...
Express News | Concord Healthcare - Shi Botao Re-Designated From Executive Director to Non-Executive Director
Express News | Concord Healthcare Group - Net Loss RMB202.0 Mln for Six Months